Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000023

CEO bought 13,500 shares at an average $0.02 ($230)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2019-04-10 Purchase : show line 1 in the form +500 $0.02 $9 21,002,123 D
2019-04-10 Purchase : show line 2 in the form +2,000 $0.02 $34 21,004,123 D
2019-04-10 Purchase : show line 3 in the form +5,000 $0.02 $85 21,009,123 D
2019-04-11 Purchase : show line 4 in the form +2,000 $0.02 $34 21,011,123 D
2019-04-12 Purchase : show line 5 in the form +2,000 $0.02 $35 21,013,123 D
2019-04-12 Purchase : show line 6 in the form +2,000 $0.02 $34 21,015,123 D
Open-market purchases · 13,500 sh · avg $0.02 · $230
Loading xslF345X03/primary_doc.xml…